NASDAQ · STOCK
Envista Holdings
$27.31
52W $18.77 – $30.42
58/100
$4.44B
65.0
0.86
⚠
Buy rating, but near-term risk/reward is unfavorable
The long-term recommendation is based on the composite investment score. The near-term risk/reward is based on nearby support and resistance levels. These can differ when a strong company trades close to resistance with support further below.
Is NVST Bullish or Bearish?
Bullish.
Innellis AI committee rates Envista Holdings (NVST) Buy with a composite score of 58/100
, based on 6 analysts with 50% agreement.
Last updated August 01, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +16.53 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -3.47 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull & Bear Case
Bull Case
- Price-to-book of 1.1x is a discount to asset value — Value
- 4 consecutive earnings beats -- consistent execution — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- P/E of 65.6 is expensive by classic value standards — Value
- ROE of only 2.2% -- cheap may mean cheap for a reason — Value
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 01, 2026
Overall Committee Score
58/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 37%
of 93 Healthcare peers
Value Analyst
neutral
50
/ 100 · High confidence
Fair value -- neither a bargain nor obviously overpriced
+ Price-to-book of 1.1x is a discount to asset value
− P/E of 65.6 is expensive by classic value standards
Growth Analyst
bullish
60
/ 100 · High confidence
Strong, accelerating growth with consistent execution
+ 4 consecutive earnings beats -- consistent execution
− Growth rate is decelerating quarter over quarter -- the trend line matters more than the level
Technical Analyst
bullish
68
/ 100 · High confidence
Price action is constructive -- trend and momentum agree
+ Price structure making higher highs and higher lows
Macro Analyst
bullish
70
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
neutral
58
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2535.03)
Investment Thesis Evolution
Committee score moved marginally from 57.5 to 58.5.
- New bearish signals: 3 appeared.
- Bullish support removed: 1 signal(s) disappeared.
- Bearish pressure eased: 3 signal(s) disappeared.
- Analyst(s) changed stance: Macro Analyst, News Analyst.
Analyst-level changes:
- Macro Analyst: stance neutral->bullish; score 58->70 (+12).
- News Analyst: stance bullish->neutral; score 64->58 (-6).
- Portfolio Manager: +2 bearish signal(s).
- Value Analyst: +1 bearish signal(s).
Comparing 2026-07-31 to 2026-08-01 (1 day apart).
Technical Analysis
RSI (14)
55.6
Neutral
MACD Histogram
0.055
Bullish Momentum
Trend Direction
Uptrend
Weekly: Sideways
Market Structure
Mixed
Support
$24.18
Resistance
$28.61
Bollinger %B
0.72
Inside Bands
Price vs Moving Averages
EMA 9
$27.15
Above
EMA 21
$26.72
Above
EMA 50
$26.09
Above
EMA 200
$24.46
Above
Fundamental Analysis
Valuation
67
Growth
69
Profitability
0
Financial Health
100
Cash Flow
37
Valuation
P/E Ratio
65.0×
P/B Ratio
1.45×
PEG Ratio
0.37
Dividend Yield
0.00%
52W High
$30.42
52W Low
$18.77
Quality & Growth
ROE
1.5%
ROA
0.8%
Gross Margin
55.1%
Operating Margin
9.0%
Revenue Growth YoY
—
Debt / Equity
0.52
AI Fundamental Assessment
P/E ratio of 65.0 (rich relative to a 15-40x range); Price-to-book of 1.5x; PEG ratio of 0.4 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 0.0%; Return on assets of 0.0%; Net margin of 0.0%; Gross margin of 0.6%; Current ratio of 2.44 (healthy short-term liquidity); Debt-to-equity of 0.52; Free cash flow margin of 0.8% (thin cash generation); Free cash flow per share is positive (1.34); Most recent quarter beat estimates by 12.9%; 4 consecutive earnings beats; EPS growth decelerating (+18.8% -> -5.3% QoQ); Analyst estimates rising over recent quarters
Get the Full NVST Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →